Stay updated on Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Sign up to get notified when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.

Latest updates to the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a software update to the ClinicalTrials.gov interface. This update seems to modify the underlying system without altering the study content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPlatform/template update from v3.5.0 to v3.5.2; trial details, eligibility criteria, and study results remain unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded a new site revision tag (v3.4.2); removed a government-funding notice and an older revision tag (v3.4.1).SummaryDifference0.4%

- Check97 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check104 days agoChange DetectedAdded a glossary display option and exposed the QC status label (Last Update Submitted that Met QC Criteria); the site revision was updated from v3.3.4 to v3.4.0 with related wording adjustments.SummaryDifference0.2%

Stay in the know with updates to Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.